Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:123165.
doi: 10.1155/2014/123165. Epub 2014 Dec 8.

RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains

Affiliations

RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains

Jun-Ichi Satoh et al. Dis Markers. 2014.

Abstract

Alzheimer's disease (AD) is the most common cause of dementia worldwide with no curative therapies currently available. Previously, global transcriptome analysis of AD brains by microarray failed to identify the set of consistently deregulated genes for biomarker development of AD. Therefore, the molecular pathogenesis of AD remains largely unknown. Whole RNA sequencing (RNA-Seq) is an innovative technology for the comprehensive transcriptome profiling on a genome-wide scale that overcomes several drawbacks of the microarray-based approach. To identify biomarker genes for AD, we analyzed a RNA-Seq dataset composed of the comprehensive transcriptome of autopsized AD brains derived from two independent cohorts. We identified the core set of 522 genes deregulated in AD brains shared between both, compared with normal control subjects. They included downregulation of neuronal differentiation 6 (NeuroD6), a basic helix-loop-helix (bHLH) transcription factor involved in neuronal development, differentiation, and survival in AD brains of both cohorts. We verified the results of RNA-Seq by analyzing three microarray datasets of AD brains different in brain regions, ethnicities, and microarray platforms. Thus, both RNA-Seq and microarray data analysis indicated consistent downregulation of NeuroD6 in AD brains. These results suggested that downregulation of NeuroD6 serves as a possible biomarker for AD brains.

PubMed Disclaimer

Figures

Figure 1
Figure 1
KEGG pathway of 470 DEGs downregulated in the frontal cortex of AD identified by RNA-Seq data analysis. Entrez Gene IDs of 470 DEGs downregulated in the frontal cortex of AD identified by RNA-Seq data analysis of SRA060572 were imported into the Functional Annotation tool of DAVID. It extracted the most significant KEGG pathway termed “neuroactive ligand-receptor interaction” (hsa04080) relevant to the set of imported genes. Downregulated genes are colored yellow.
Figure 2
Figure 2
IPA pathways of the core set of 522 DEGs in the frontal cortex of AD identified by RNA-Seq data analysis. Entrez Gene IDs of 522 DEGs in the frontal cortex of AD identified by RNA-Seq data analysis of SRA060572 were imported into the Core Analysis tool of IPA. It extracted the most significant functional network termed “Hereditary Disorder, Neurological Disease, Psychological Disorders” relevant to the set of imported genes. Downregulated DEGs are colored green, while upregulated DEGs are colored red. NeuroD6 is highlighted by a blue circle.

Similar articles

Cited by

References

    1. Gatz M., Reynolds C. A., Fratiglioni L., Johansson B., Mortimer J. A., Berg S., Fiske A., Pedersen N. L. Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry. 2006;63(2):168–174. doi: 10.1001/archpsyc.63.2.168. - DOI - PubMed
    1. Walton J. R. Aluminum's involvement in the progression of alzheimer's disease. Journal of Alzheimer's Disease. 2013;35(1):7–43. doi: 10.3233/JAD-121909. - DOI - PubMed
    1. Squitti R., Siotto M., Polimanti R. Low-copper diet as a preventive strategy for Alzheimer's disease. Neurobiology of Aging. 2014;35(2):S40–S50. doi: 10.1016/j.neurobiolaging.2014.02.031. - DOI - PubMed
    1. Rosenthal S. L., Kamboth M. I. Late-onset Alzheimer’s disease genes and the potentially implicated pathways. Current Genetic Medicine Reports. 2014;2:85–101. - PMC - PubMed
    1. Jonsson T., Atwal J. K., Steinberg S., Snaedal J., Jonsson P. V., Bjornsson S., Stefansson H., Sulem P., Gudbjartsson D., Maloney J., Hoyte K., Gustafson A., Liu Y., Lu Y., Bhangale T., Graham R. R., Huttenlocher J., Bjornsdottir G., Andreassen O. A., Jönsson E. G., Palotie A., Behrens T. W., Magnusson O. T., Kong A., Thorsteinsdottir U., Watts R. J., Stefansson K. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature. 2012;487(7409):96–99. doi: 10.1038/nature11283. - DOI - PubMed

Publication types

Substances

LinkOut - more resources